Yale Scleroderma Program

Bringing together expertise, compassion, and innovation to empower individuals affected by scleroderma. Research:

[Yale Scleroderma Program @YaleScleroderma]

Published! Scleroderma investigators led by Yale team applied AI to longitudinal skin biopsies from SSc pts enrolled belumosudil trial. First-of-its-kind AI-generated Fibrosis Score measures scleroderma features beyond fibrosis & may be a useful outcome.

https://t.co/7IPIr5JDW6

[Yale Scleroderma Program @YaleScleroderma]

#Scleroderma

[amykaufman @amykaufman84]

Annie Turcotte was a woman ahead of her time: committed to nature and finding ways to protect it. She was 21 years old when she was killed. Her mother said that despite the years, Turcotte is “forever our darling daughter… We’ve always kept her very much alive in our house.”

[Yale Scleroderma Program @YaleScleroderma]

@YaleRheumAller1

[Yale Scleroderma Program @YaleScleroderma]

Thank you Dr Johnson for your leadership on creating ACR ILD guidelines

[American College of Rheumatology @ACRheum]

It’s Sunday here at #ACR23 & we’ve got another great episode for you straight from the SDCC! The new ACR Interstitial Lung Disease Guidelines have been published & we have first author @SindhuJohnson5 here to discuss them. Listen → https://t.co/TU8q0CZGRm

[Yale Scleroderma Program @YaleScleroderma]

Yale booth at #acr23

[Yale Scleroderma Program @YaleScleroderma]

@YaleRheumAller1

[Yale Scleroderma Program @YaleScleroderma]

@YaleRheumAller1

[Yale Scleroderma Program @YaleScleroderma]

@YaleRheumAller1

[Yale Scleroderma Program @YaleScleroderma]

Will Odell, BS, Yale Rheumatology Clinical and Translational Research Laboratory member presents his work with Dr Abhijeet Danve at #ACR2023 on AxSpA and inflammatory back pain. Congrats!

[Naftali Kaminski @KaminskiMed]

In Jerusalem 👇🏼

[American College of Rheumatology @ACRheum]

It’s Sunday here at #ACR23 & we’ve got another great episode for you straight from the SDCC! The new ACR Interstitial Lung Disease Guidelines have been published & we have first author @SindhuJohnson5 here to discuss them. Listen → https://t.co/TU8q0CZGRm

[Yale Scleroderma Program @YaleScleroderma]

A visitor to my mentee’s poster today: Harris Perlman PhD, Section Head, Northwestern Rheumatology

[Yale Scleroderma Program @YaleScleroderma]

Baran Ilayda Gunes, BA, Yale Scleroderma Program, presents her work assessing the utility of Deep Neural Network algorithm applied to scleroderma skin biopsies as early skin outcome. Better skin outcomes are needed for scleroderma clinical trials

[Yale Scleroderma Program @YaleScleroderma]

Will Odell BS, Yale Rheumatology Clinical and Translational Research Laboratory, at awards ceremony for American College of Rheumatology Travel Award recipients. Congrats!

[Yale Scleroderma Program @YaleScleroderma]

Check out Serena Crawford’s new Raynaud Phenomenon article featuring our very own Dr. Monique Hinchcliff in the Yale Today newsletter! @YaleIMed @YaleRheumAller1 @YaleMed https://t.co/XeqKk9URAn

[Yale Scleroderma Program @YaleScleroderma]

For a glimpse into our program’s research endeavors, please access our website using the provided link: https://t.co/qsw4bQBHYY

[Yale Scleroderma Program @YaleScleroderma]

Today on #WorldSclerodermaDay we honor those who are affected by scleroderma. Let us continue to raise awareness, spread hope, and pour into the research that will help us better understand how to serve our #scleroderma community! 🩵

[Naftali Kaminski @KaminskiMed]

The Hassoun tour de force continues at noon & and today it’s - Pulmonary Hypertension: A Translational Approach! And a focus on Scleroderma PAH! really exciting! #YaleGreatTalks #YalePCCSMResearchConference #CurePAH #CureSSC

[@Yale Rheum/Allergy @YaleRheumAller1]

Exciting new paper coauthored by Dr. Monique Hinchcliff from @YaleRheumAller1 @YaleScleroderma
Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients
https://t.co/weX10cgBZw